Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
-$4.81B |
 |
TeleflexTFX |
-$40M |
 |
Universal Health ServicesUHS |
-$42M |
 |
HCA HealthcareHCA |
-$232M |
 |
ProgynyPGNY |
-$1.14B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| SZOSTAK M ANNE | Sep 6, 2024 | Sell | 500 | $469.3723 | $230,000 |
| Claflin Bruce L. | May 17, 2024 | Sell | 200 | $540.8 | $110,000 |
| POLEWACZYK JAMES F | Mar 6, 2024 | Sell | 4,134 | $557.941 | $2.3M |
| POLEWACZYK JAMES F | Mar 6, 2024 | Sell | 3,290 | $558.8822 | $1.8M |
| POLEWACZYK JAMES F | Mar 6, 2024 | Sell | 680 | $559.3318 | $380,000 |
| Vandebroek Sophie V. | Mar 5, 2024 | Sell | 1,404 | $562.9822 | $790,000 |
| FENNELL GEORGE | Feb 8, 2024 | Sell | 3,173 | $575.0167 | $1.8M |
| FENNELL GEORGE | Feb 8, 2024 | Sell | 2,279 | $572.7797 | $1.3M |
| FENNELL GEORGE | Feb 8, 2024 | Sell | 1,209 | $572.1356 | $690,000 |
| FENNELL GEORGE | Feb 8, 2024 | Sell | 1,125 | $573.9761 | $650,000 |
| FENNELL GEORGE | Feb 8, 2024 | Sell | 412 | $575.8027 | $240,000 |
| MCKEON BRIAN P | Feb 7, 2024 | Sell | 7,128 | $571.8381 | $4.1M |
| MCKEON BRIAN P | Feb 7, 2024 | Sell | 5,675 | $570.9697 | $3.2M |
| MCKEON BRIAN P | Feb 7, 2024 | Sell | 3,912 | $569.9132 | $2.2M |
| MCKEON BRIAN P | Feb 7, 2024 | Sell | 1,581 | $564.976 | $890,000 |
| MCKEON BRIAN P | Feb 7, 2024 | Sell | 1,564 | $567.3487 | $890,000 |
| MCKEON BRIAN P | Feb 7, 2024 | Sell | 1,469 | $568.8449 | $840,000 |
| MAZELSKY JONATHAN JAY | Feb 7, 2024 | Sell | 5,356 | $571.7066 | $3.1M |
| MAZELSKY JONATHAN JAY | Feb 7, 2024 | Sell | 4,124 | $572.5253 | $2.4M |
| MAZELSKY JONATHAN JAY | Feb 7, 2024 | Sell | 1,353 | $574.7515 | $780,000 |
| MCKEON BRIAN P | Feb 7, 2024 | Sell | 701 | $566.533 | $400,000 |
| MCKEON BRIAN P | Feb 7, 2024 | Sell | 681 | $572.8041 | $390,000 |
| MCKEON BRIAN P | Feb 7, 2024 | Sell | 615 | $563.8158 | $350,000 |
| MAZELSKY JONATHAN JAY | Feb 7, 2024 | Sell | 705 | $575.4769 | $410,000 |
| MAZELSKY JONATHAN JAY | Feb 7, 2024 | Sell | 462 | $573.1911 | $260,000 |
| POLEWACZYK JAMES F | Dec 7, 2023 | Sell | 3,940 | $523.5563 | $2.1M |
| POLEWACZYK JAMES F | Dec 7, 2023 | Sell | 3,378 | $521.0046 | $1.8M |
| POLEWACZYK JAMES F | Dec 7, 2023 | Sell | 3,116 | $520.1922 | $1.6M |
| POLEWACZYK JAMES F | Dec 7, 2023 | Sell | 1,202 | $522.3094 | $630,000 |
| MAZELSKY JONATHAN JAY | Dec 4, 2023 | Sell | 5,804 | $512.95 | $3M |
| MAZELSKY JONATHAN JAY | Dec 4, 2023 | Sell | 1,324 | $513.51 | $680,000 |
| MAZELSKY JONATHAN JAY | Aug 31, 2023 | Sell | 13,424 | $512.0133 | $6.9M |
| POLEWACZYK JAMES F | Aug 29, 2023 | Sell | 7,473 | $511.0286 | $3.8M |
| POLEWACZYK JAMES F | Aug 29, 2023 | Sell | 6,186 | $510.3776 | $3.2M |
| POLEWACZYK JAMES F | Aug 29, 2023 | Sell | 3,318 | $510.4664 | $1.7M |
| POLEWACZYK JAMES F | Aug 29, 2023 | Sell | 2,887 | $511.2237 | $1.5M |
| POLEWACZYK JAMES F | Aug 29, 2023 | Sell | 2,545 | $509.3207 | $1.3M |
| POLEWACZYK JAMES F | Aug 29, 2023 | Sell | 500 | $508.9642 | $250,000 |
| AYERS JONATHAN W | Aug 15, 2023 | Sell | 492 | $0 | $0 |
| Lane Michael | Aug 3, 2023 | Sell | 16,027 | $510 | $8.2M |
| AYERS JONATHAN W | May 19, 2023 | Sell | 2,254 | $487.8169 | $1.1M |
| AYERS JONATHAN W | May 19, 2023 | Sell | 1,426 | $492.8167 | $700,000 |
| AYERS JONATHAN W | May 19, 2023 | Sell | 1,308 | $488.7748 | $640,000 |
| AYERS JONATHAN W | May 19, 2023 | Sell | 1,229 | $494.276 | $610,000 |
| AYERS JONATHAN W | May 19, 2023 | Sell | 1,138 | $486.9211 | $550,000 |
| AYERS JONATHAN W | May 19, 2023 | Sell | 886 | $495.9351 | $440,000 |
| AYERS JONATHAN W | May 19, 2023 | Sell | 759 | $497.6556 | $380,000 |
| AYERS JONATHAN W | May 19, 2023 | Sell | 400 | $491.59 | $200,000 |
| AYERS JONATHAN W | May 19, 2023 | Sell | 300 | $498.48 | $150,000 |
| AYERS JONATHAN W | May 18, 2023 | Sell | 2,753 | $487.8353 | $1.3M |
| AYERS JONATHAN W | May 18, 2023 | Sell | 2,242 | $489.7081 | $1.1M |
| AYERS JONATHAN W | May 18, 2023 | Sell | 1,695 | $490.7719 | $830,000 |
| AYERS JONATHAN W | May 18, 2023 | Sell | 1,298 | $491.9058 | $640,000 |
| AYERS JONATHAN W | May 18, 2023 | Sell | 1,012 | $488.6343 | $490,000 |
| AYERS JONATHAN W | May 18, 2023 | Sell | 1,000 | $486.482 | $490,000 |
| Lane Michael | May 5, 2023 | Sell | 1,000 | $484 | $480,000 |
| SZOSTAK M ANNE | May 5, 2023 | Sell | 800 | $475.27 | $380,000 |
| SZOSTAK M ANNE | May 5, 2023 | Sell | 700 | $473.59 | $330,000 |
| SZOSTAK M ANNE | May 5, 2023 | Sell | 500 | $476.12 | $240,000 |
| Vandebroek Sophie V. | May 4, 2023 | Sell | 2,187 | $469.0169 | $1M |
| JUNIUS DANIEL M | Feb 16, 2023 | Sell | 2,187 | $511.6797 | $1.1M |
| Turner Kathy V | Feb 16, 2023 | Sell | 10 | $515.575 | $5,200 |
| Turner Kathy V | Feb 15, 2023 | Sell | 1,000 | $510.0312 | $510,000 |
| Turner Kathy V | Feb 14, 2023 | Sell | 1,000 | $505.059 | $510,000 |
| Turner Kathy V | Feb 14, 2023 | Sell | 577 | $504.0923 | $290,000 |
| Turner Kathy V | Feb 14, 2023 | Sell | 313 | $504.6616 | $160,000 |
| Turner Kathy V | Feb 14, 2023 | Sell | 110 | $502.814 | $55,000 |
| Turner Kathy V | Feb 9, 2023 | Sell | 1,000 | $505.0374 | $510,000 |
| JUNIUS DANIEL M | Dec 5, 2022 | Sell | 3,046 | $424.91 | $1.3M |
| SZOSTAK M ANNE | Dec 2, 2022 | Sell | 740 | $428.55 | $320,000 |
| Turner Kathy V | Dec 1, 2022 | Sell | 3,000 | $436 | $1.3M |
What's the latest insider transaction for Idexx Laboratories?
The most recent insider transaction for Idexx Laboratories was conducted by SZOSTAK M ANNE, who sold 500 shares on September 6, 2024 at a price of $469.37 per share.
Which insider has sold the most IDXX stock over the last two years?
POLEWACZYK JAMES F has sold the most IDXX stock in the last 2 years, with a total value of $22M.
What is the total value of insider transactions for Idexx Laboratories (IDXX) in the last 2 years?
The total value of insider transactions for Idexx Laboratories in the last 2 years is negative, amounting to -$85M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Idexx Laboratories' market confidence?
Over the last 2 years, insider transactions for Idexx Laboratories have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
